Merck | MRK - Gross Profit On Sales


Merck reported EUR3.07B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Adidas EUR 3.54B 171M Jun/2026
Adyen EUR 1.08B 788.66M Dec/2024
Akzo Nobel EUR 978M 42M Mar/2026
Alcon AG USD 1.69B 175M Mar/2026
Amadeus IT EUR 754.9M 225.7M Mar/2026
Amarin USD 23.17M 961K Dec/2025
AstraZeneca USD 12.86B 251M Jun/2026
BASF EUR 4.33B 181M Jun/2026
Bayer EUR 8.17B 1.24B Mar/2026
Beiersdorf EUR 1.54B 1.16B Jun/2025
Covestro EUR 212M 276M Dec/2025
Danone EUR 6.82B 23M Dec/2024
Fresenius EUR 1.55B 16M Jun/2026
Fresenius Medical Care EUR 1.18B 210M Mar/2026
Genmab DKK 831M 146M Mar/2026
Givaudan CHF 1.55B 140M Dec/2025
GlaxoSmithKline GBP 6.51B 757M Jun/2026
GRIFOLS EUR 704M 84M Jun/2026
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Infineon EUR 1.48B 15M Mar/2026
Lakefront Biotherapeutics EUR 1.68M 898.68M Mar/2026
Linde USD 4.26B 991M Mar/2026
Lonza CHF 1.29B 248M Jun/2025
Merck EUR 3.07B 104M Mar/2026
Novartis USD 11.24B 1.18B Jun/2026
Philips EUR 2.15B 384M Jun/2026
Roche Holding CHF 22.69B 600M Jun/2026
Sanofi EUR 8.71B 602M Jun/2026
UCB EUR 3.19B 621M Dec/2025